Universitätsklinikum Schleswig-Holstein (UKSH)

Mycophenolate Mofetil for the Treatment of Ipilimumab-induced Autoimmune Colitis in Patients with metastatic Melanoma (2019) Naoum C, Majenka P, Loquai C, Kaehler K, Heinzerling L, Dudda M, Hassel J Conference contribution Implementation of Guidelines (2019) Nothacker M, Hofmann W, Bahrmann P, Volkert D, Frohnhofen H, Sirsch E, Muth C, Becher KF Conference contribution Platelets and Immune Responses During Thromboinflammation (2019) Mezger M, Nording H, Sauter R, Graf T, Heim C, Von Bubnoff N, Ensminger SM, Langer HF Journal article, Review article The German National Registry of Primary Immunodeficiencies (2012-2017) (2019) El-Helou SM, Biegner AK, Bode S, Ehl SR, Heeg M, Maccari ME, Ritterbusch H, et al. Journal article Intratumoral RNA-based TLR-7/-8 and RIG-I agonist CV8102 alone and in combination with anti-PD-1 in a Phase I dose-escalation and expansion trial in patients with advanced solid tumors (2019) Eigentler T, Krauss J, Schreiber J, Weishaupt C, Terheyden P, Heinzerling L, Mohr P, et al. Conference contribution Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study (2019) Wallwiener M, Nabieva N, Feisst M, Fehm T, De Waal J, Rezai M, Baier B, et al. Journal article Patient views on research use of clinical data without consent: Legal, but also acceptable? (2019) Richter G, Borzikowsky C, Lieb W, Schreiber S, Krawczak M, Buyx A Journal article Favorable radiation field decrease in gastric marginal zone lymphoma Experience of the German Study Group on Gastrointestinal Lymphoma (DSGL) (2019) Reinartz G, Pyra RP, Lenz G, Liersch R, Stueben G, Micke O, Willborn K, et al. Journal article High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer (2019) Bick U, Engel C, Krug B, Heindel W, Fallenberg EM, Rhiem K, Maintz D, et al. Journal article Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto (2019) Laakmann E, Witzel I, Fasching P, Rezai M, Schem C, Solbach C, Tesch H, et al. Journal article